MB&P Tools & Diagnostics

Clinical Development Concept Completeness Check: Is the Study Concept Ready to Become a Protocol?

A concept sheet can contain many protocol details and still be strategically incomplete. Before drafting accelerates, the team should be able to explain what decision the study is intended to unlock, which evidence threshold matters and how the design connects to the next regulatory, payer, operational and financing gate.

The decision problem. Incomplete concepts create expensive downstream corrections. The protocol team fills in missing assumptions, feasibility is asked to validate a design rather than challenge it, and regulatory or payer requirements arrive after key choices have hardened.

When this diagnostic is useful

Before an irreversible commitment

Use it before a protocol lock, pivotal-design decision, regulatory interaction, major vendor commitment, financing gate, partnering discussion or repeat-study decision.

When the team is not converging

Use it when different functions are giving individually reasonable answers that do not yet add up to one defensible development decision.

What to pressure-test

Development decision and value hypothesis
Clinical rationale and target population
Objective, endpoint, estimand and comparator alignment
Eligibility criteria tested against real patient availability
Visit schedule, procedures and patient/site burden
Safety monitoring, discontinuation and rescue logic
Statistical assumptions and decision criteria
Clinical development strategy and next study logic
Regulatory interaction and submission purpose
Country, site and execution architecture
Evidence that would trigger redesign, pause or termination

Red flags

The team can describe the protocol but not the decision it is meant to support.
Feasibility begins after the population and schedule are already fixed.
Regulatory purpose and payer relevance are implicit rather than written.
There is no stated evidence threshold for redesign or stop.

Why this matters to capital

The concept stage is where design changes are still cheap. Once protocol writing, vendor contracting and site activation begin, missing decisions become change orders, amendments and lost runway.

What changes after a useful review

A useful diagnostic does not end with a score. It identifies the dominant uncertainty, distinguishes what is known from what is assumed, shows which decision is currently exposed and defines the smallest next action capable of changing that decision.

Illustrative outcome from selected work. In early neurodegeneration work, integrated endpoint, biomarker, population and risk-gate logic created a decision-grade path from early safety and pharmacodynamic data to Phase II/III planning.

Download the one-page diagnostic

The downloadable version is intentionally concise. It is designed to structure an internal discussion and reveal where a programme-specific review may be warranted; the full professional working method is not published.

Download the Clinical Development Concept Completeness Check PDF

Related expertise

Clinical Development Strategy & Pivotal Trial Design Clinical-development strategy insights Results & case snapshots

Start with the decision, not the deliverable

Use the check before protocol drafting becomes the programme’s substitute for development strategy.

Start with a 20-minute Clinical Decision Diagnostic

Bring one live decision, the next hard milestone and the time available. The first conversation is designed to determine whether focused senior intervention can create material value.

Educational decision-support tool. It does not replace programme-specific medical, statistical, regulatory, operational, financial or legal review.